|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07J 9/00 | (2006.01) |
| A61K 31/575 | (2006.01) | ||
| A61P 1/16 | (2006.01) | ||
| C07J 31/00 | (2006.01) | ||
| C07J 41/00 | (2006.01) |
| (11) | Number of the document | 3149019 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15731260.4 |
| Date of filing the European patent application | 2015-05-28 | |
| (97) | Date of publication of the European application | 2017-04-05 |
| (45) | Date of publication and mention of the grant of the patent | 2019-12-04 |
| (46) | Date of publication of the claims translation | 2020-02-25 |
| (86) | Number | PCT/EP2015/061802 |
| Date | 2015-05-28 |
| (87) | Number | WO 2015/181275 |
| Date | 2015-12-03 |
| (30) | Number | Date | Country code |
| FI20140130 | 2014-05-29 | IT |
| (72) |
ZAMPELLA, Angela, IT
FIORUCCI, Stefano, IT
|
| (73) |
Bar Pharmaceuticals S.r.l.,
Via Sicilia, 2, 42124 Reggio Nell`Emilia,
IT
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Cholano dariniai, skirti naudoti FXR ir TGR5/GPBAR1 medijuojamų ligų gydymui ir (arba) prevencijai |
| CHOLANE DERIVATIVES FOR USE IN THE TREATMENT AND/OR PREVENTION OF FXR AND TGR5/GPBAR1 MEDIATED DISEASES |
| Payment date | Validity (years) | Amount | |
| 2025-05-07 | 11 | 289.00 EUR |
| 2026-05-28 |